3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Recruiting
1
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Dermatologic
1
Conditions
Breast Neoplasms
14
Neoplasms
11
Carcinoma, Non-Small-Cell Lung
10
Colorectal Neoplasms
9
Prostatic Neoplasms
8
Lung Neoplasms
7
Melanoma
6
Pancreatic Neoplasms
5
Head and Neck Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Neoplastic Cells, Circulating
4
Hematologic Neoplasms
4
Stomach Neoplasms
3
Neoplasm Metastasis
3
Leukemia, Myeloid, Acute
3
Leukemia
3
Glioblastoma
3
Carcinoma, Hepatocellular
3
Uterine Cervical Neoplasms
2
Thyroid Neoplasms
2
Sarcoma
2
Recurrence
2
Ovarian Neoplasms
2
Oropharyngeal Neoplasms
2
Myelodysplastic Syndromes
2
Lymphoma, Non-Hodgkin
2
Liver Diseases
2
Kidney Neoplasms
2
Glioma
2
Fibrosis
2
Interventions
Etoposide
23
Cisplatin
15
Carboplatin
13
Irinotecan
12
apatinib
11
anlotinib
10
durvalumab
7
Topotecan
6
toripalimab
4
surufatinib
4
sintilimab
4
atezolizumab
4
Temozolomide
4
Drug Therapy
4
tislelizumab
3
lobaplatin
3
camrelizumab
3
Simvastatin
3
Radiotherapy
3
Ifosfamide
3
Albumin-Bound Paclitaxel
3
pembrolizumab
2
pegylated granulocyte colony-stimulating factor
2
olaparib
2
niraparib
2
isophosphamide mustard
2
avelumab
2
X-Rays
2
Platinum
2
Nivolumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Small Cell Lung Carcinoma
×
Blood Specimen Collection
×
Clear all
NCT02105168
2016-06-10
MSN
Gustave Roussy, Cancer Campus, Grand Paris
Phase NA
Unknown
2,200 enrolled